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Objectives. In the present study, we examined post-stenotic
coronary ﬂow before and after percutaneous transluminal coro-
nary angioplasty (PTCA) in patients with and without a recent
myocardial infarction (MI) and related it to stenosis severity and
residual viability.
Background. Post-stenotic coronary blood ﬂow velocity reserve
(CFVR) has been used with success to estimate functional stenosis
severity in patients with stable angina. However, in patients with
a recent MI, the impaired coronary vasodilator response of the
reperfused myocardium may substantially alter the ﬂow dynamics
of the infarct-related artery.
Methods. Distal coronary ﬂow velocities were recorded before
and after PTCA in 36 patients at day 13  7 (mean  SD) after
acute MI and in 38 patients without MI. The CFVR was assessed
by the ratio of distal hyperemic to baseline average peak velocity,
using a 0.014-in. Doppler guide wire. Stenosis severity was ana-
lyzed by quantitative coronary angiography, and infarct size was
assessed scintigraphically.
Results. For similar angiographic stenosis severity, pre- and
post-PTCA values of CFVR were signiﬁcantly lower in patients with
than without MI: 1.22  0.26 versus 1.50  0.45 before PTCA (p <
0.05) and 1.72  0.43 versus 2.21  0.74 after PTCA, respectively
(p < 0.01). Although CFVR increased signiﬁcantly (p < 0.0001) after
angiographically successful PTCA in both study groups, abnormal
CFVR (<2.0) was still observed in 80% of patients with MI and in
44% of those without MI (MI vs. no MI, p 0.001). Patients with an
extensive infarction (relative infarct size >50%) and those with a
small infarction (relative infarct size <50%) had comparable levels
of post-PTCA CFVR (1.6  0.3 vs. 1.8  0.5, p  NS). Among a
variety of factors, angiographic stenosis severity was the most
important determinant of CFVR in both study groups.
Conclusions. In patients with a recent MI, CFVR was signiﬁ-
cantly lower than in those without MI, both before and after
PTCA. Besides the presence of this postreperfusion-related im-
pairment of the coronary vasodilating response, CFVR was mainly
inﬂuenced by stenosis severity and not by residual viability.
(J Am Coll Cardiol 1996;28:1712–9)
1996 by the American College of Cardiology
Coronary angiography is commonly used to assess the severity
of coronary artery disease. However, coronary anatomy may
not reﬂect the functional signiﬁcance of coronary stenosis
(1,2). Experimental studies have demonstrated (3,4) that cor-
onary ﬂow reserve is a reliable marker of the physiologic
signiﬁcance of a given coronary obstruction. The recent devel-
opment of an intracoronary Doppler guide wire has facilitated
routine measurement of coronary ﬂow velocity and coronary
ﬂow velocity reserve (CFVR) both proximal and distal to
coronary artery lesions (5). Recent clinical studies (6,7) in
patients with angiographically intermediate coronary artery
stenoses have demonstrated good correlation between Dopp-
ler-derived post-stenotic intracoronary ﬂow reserve and stress
perfusion scintigraphy with either thallium-201 or technetium-
99m sestamibi. Furthermore, there is early clinical evidence
(8,9) that Doppler ﬂow measurements during percutaneous
transluminal coronary angioplasty (PTCA) give important
information about the short- and medium-term functional
outcome of the early angioplasty result. Most of these studies
evaluated patients with stable angina. Less is known with
regard to coronary ﬂow dynamics in patients with a myocardial
infarction (MI). Experimental work on reperfusion models and
recent clinical studies with perfusion imaging techniques have
shown (10–12) that the coronary vasodilating response is
severely impaired after a transient occlusion of the target
vessel. To assess the extent of this impaired ﬂow response of
the reperfused myocardium and to study its effect on the
coronary ﬂow dynamics of the infarct-related artery during
PTCA, ﬂow velocities were recorded before and after PTCA in
patients with a recent MI and were compared with ﬂow
velocity data from a matched control group of patients with
stable angina and no MI. In addition, the relation of coronary
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ﬂow velocity reserve to angiographic stenosis severity and
residual viability was examined.
Methods
Study patients. A total of 74 patients (56 men, 19 women;
mean [SD] age 63  9 years, range 37 to 80) undergoing
elective PTCA of nonocclusive signiﬁcant stenosis (50%
diameter stenosis [DS]) in a native coronary artery were
prospectively enrolled in the study. The decision to perform
elective PTCA was based on angiographic and clinical ﬁndings.
Patients with valvular disease, congestive heart failure and
signiﬁcant left ventricular hypertrophy, as deﬁned electrocar-
diographically, were excluded from the study. Angiographic
exclusions included collateral supply, bypass graft to the target
vessel, ostial narrowing inducing wedging of the catheter, distal
lesions with a small perfusion bed and lesions not eligible to be
crossed by the Doppler coronary guide wire. In three patients
with stable angina pectoris, repeated angioplasty was per-
formed because of restenosis, so that in the total cohort of 74
patients, intracoronary ﬂow velocity measurements were ob-
tained for 77 lesions.
The study group included 36 patients with a recent (1
month) MI and 38 patients without MI. Twenty-seven (75%)
patients with MI received thrombolytic therapy, and 31 devel-
oped electrocardiographic evidence of a transmural infarction
(Q wave in at least two leads or r/s wave in leads V1 to V2 1).
Clinical characteristics of both subgroups are summarized in
Table 1. Evaluation of cardiac risk factors was based on the
presence or absence of a serum cholesterol level 240 mg%,
arterial hypertension, current smoking and diabetes mellitus.
Cardiovascular medications (nitrates, beta-adrenergic blocking
agents, calcium channel antagonists, antiplatelet agents) were
continued as clinically indicated. Informed consent was ob-
tained from all patients, and the protocol was approved by the
institutional ethical committee of the University Hospital of
Antwerp.
Catheterization procedure. Cardiac catheterization was
performed on day 13  7 (range 4 to 30) after acute MI.
Diagnostic coronary arteriography was done with standard
catheters and conventional orthogonal views. The left ventricu-
logram was obtained in the right and left anterior oblique
projections with 20 of cranial angulation.
The angioplasty procedure was performed after intravenous
administration of 10,000 U of heparin. A continuous infusion
of intravenous isosorbide dinitrate (0.5 g/kg body weight per
min) and dextran (100 ml/h) was started 30 min before
procedure.
Coronary ﬂow velocity measurements were done with a
0.014-in. Doppler angioplasty guide wire (FloWire, Cardio-
metrics) after intracoronary administration of isosorbide dini-
trate (1 mg). Continuous ﬂow velocity data along with simul-
taneous electrocardiography and aortic pressure waveforms
were displayed on the video monitor and recorded continu-
ously on Super-VHS videotape.
Distal ﬂow velocities were obtained at least 2 cm beyond the
stenosis at baseline and again during coronary hyperemia induced
by administration of intracoronary adenosine (18-g bolus for the
left main and 12-g for the right coronary artery). The maximal
hyperemic response after adenosine injection was automatically
detected and reported on the video printer. Systolic, diastolic and
mean arterial pressures and heart rate were recorded on a
multichannel recorder (Siemens) during baseline conditions and
20 s after intracoronary injection of adenosine. Rate-pressure
product (mm Hg  beats per min) was calculated as heart rate
multiplied by systolic arterial pressure. After measurement of the
hyperemic response, coronary angiography was performed to
deﬁne the lumen diameter at the site of the Doppler sample
volume. Angioplasty was then carried out and completed in
accordance with standard clinical and angiographic judgment.
Fifteen minutes after angiographically successful PTCA, baseline
and hyperemic distal ﬂow velocity data were again obtained as
before angioplasty.
Angiographic data analysis. Coronary angiographic ﬁlms
were quantitatively analyzed with a computer-based Cardio-
vascular Angiography Analysis System (CAAS II, Pie Medical
Data, Maastricht, The Netherlands), which has been previously
described in detail (13). End-diastolic frames that showed the
narrowest stenotic diameter were selected and digitized. The
absolute diameter of the lesion (in mm) was determined using
the tip of the guiding catheter as a scaling device. Stenosis
Abbreviations and Acronyms
ANOVA  analysis of variance
APV  time-averaged peak velocity
CFVR  coronary ﬂow velocity reserve
CSA  cross-sectional area
DS  diameter stenosis
DSVR  diastolic/systolic velocity ratio
MI  myocardial infarction
MLD  minimal lumen diameter
PTCA  percutaneous transluminal coronary angioplasty
SPECT  single-photon emission computed tomography
Table 1. Clinical Characteristics of Study Patients
No MI
(n  38)
MI
(n  36) p Value
Age (yr) 63  9 62  10 0.8
Male/female 28/10 27/9 0.9
Hypertension 10 (26) 12 (33) 0.5
Cholesterol (mg) 226  43 212  59 0.3
Diabetes mellitus 5 (13) 5 (14) 0.9
Smoker 11 (29) 17 (47) 0.1
No. of risk factors 1.1 1.0 1.2  0.8 0.7
1/2/3 VD 31/7/0 29/7/0 0.9
Ejection fraction (%) 70  6 59  12  0.0001
Medications
Beta-blocker 25 (66) 28 (78) 0.3
Nitrates 22 (58) 21 (58) 0.9
Ca channel blocker 20 (53) 3 (8)  0.0001
Data presented are mean value  SD, number of patients or number (%) of
patients. Ca  calcium; MI  myocardial infarction; VD  vessel disease.
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severity was calculated from the minimal lumen diameter
(MLD) and a computer-estimated reference diameter and
expressed as percent diameter stenosis (%DS) and minimal
cross-sectional area (CSA). Signiﬁcant coronary artery stenosis
was deﬁned as lumen diameter stenosis 50% in a major
epicardial coronary artery or branch.
Left ventricular ejection fraction was calculated using end-
diastolic and end-systolic frames in the 30 right anterior
oblique projection. End-diastolic and end-systolic volumes
were derived by the area–length ellipsoid method (14).
Coronary ﬂow velocity data analysis. The Doppler guide
wire was connected to the 15-MHz pulsed-Doppler velocime-
ter (FloMap, Cardiometrics), which analyzed on-line Doppler
velocity spectra and calculated the temporal average of the
instantaneous peak velocity waveform both during baseline
conditions and during maximal hyperemia. Coronary ﬂow
velocity reserve was then computed as the ratio of hyperemic
to baseline average peak velocity of the distal vessel. Although
the Doppler guide wire measures only relative velocity changes
and not the absolute volumetric ﬂow, ﬂow velocity measure-
ments can be used as an accurate indicator of coronary ﬂow
reserve, provided that the vessel CSA is constant during
hyperemia. Intracoronary bolus injection of adenosine does
not modify coronary lumen diameter (15); therefore, CFVR
should closely reﬂect volumetric coronary ﬂow reserve. On the
basis of previous studies (6,7), a CFVR 2.0 was considered
abnormal.
A quantitative estimate of coronary ﬂow (ml/min) distal to
the lesion was calculated as the arterial CSA (mm2) at the site
of the Doppler sample volume multiplied by 1/2 of the
time-averaged peak velocity (APV [cm/s]) times 0.6 (unit
conversion factor). In addition, the diastolic/systolic velocity
ratio (DSVR) was calculated from the ratio of the diastolic
APV to the systolic APV.
Rest technetium-99m sestamibi single-photon emission
computed tomography (SPECT). Scintigraphic studies were
performed in patients with MI 6  3 days (range 2 to 13) after
angioplasty. Tomographic acquisition of the tracer distribution
was performed 1 to 3 h after injection of 555 MBq of
technetium-99m-labeled sestamibi by means of SPECT with a
circular ﬁeld rotating gamma camera (Sophycamera CF, Sopha
Medical, Buc, France).
Regional Tc-99m sestamibi activity was visually analyzed on a
17-segment left ventricular model by consensus of two expert
observers (B.K., M.C.) who had no knowledge of the angio-
graphic and coronary ﬂow data. For the purpose of the present
study, a binary scintigraphic uptake score was used to assess
viability. Segments showing normal or moderately reduced tracer
activity (50% of maximal activity) were considered viable.
Segments with severe reduction of tracer activity (50% of
maximal activity) were considered necrotic. Technetium-99m ses-
tamibi has been shown (16,17) to be a good viability tracer at least
in regions supplied by a vessel without severe residual stenosis. To
avoid the effect of hypoperfusion due to severe residual stenosis
on the total tracer activity within the infarct region, the scinti-
graphic study was performed after PTCA. Because no patient
showed clinical evidence of an early restenotic process (recurrent
angina or infarction) after PTCA, the infarct-related artery was
assumed not to be severely stenotic at the time of the rest
scintigraphic study.
Absolute infarct size was deﬁned as the number of necrotic
segments within the infarct risk area. The infarct risk area
corresponded to the vascular territory distal to the infarct-
related vessel stenosis and was assigned by carefully taking into
account the localization of the lesion (proximal or mid) and the
presence of major branches (diagonal, marginal, inferolateral,
posterior descending), as previously described (18). Relative
infarct size was expressed as the ratio of absolute infarct size to
infarct risk area and was used as a marker of residual viability.
Patients with a relative infarct size 50% were considered to
have a small infarction, whereas a relative infarct size 50%
indicated an extensive infarction.
Statistical analysis. Results are expressed as mean value
SD. Demographic, angiographic and coronary ﬂow variables
for the two study groups were compared by chi-square analysis
for categoric variables and by analysis of variance (ANOVA)
for continuous variables. Comparison between both study
groups of pre-PTCA and post-PTCA data was done by two-
way repeated measures ANOVA with a post hoc Student-
Newman-Keuls test to evaluate differences. To identify the
determinants of CFVR, the relation between CFVR and
angiographic, scintigraphic and clinical variables was examined
by forward stepwise linear regression analysis, with Fenter  4
and Fremove  3.9. The relation between CFVR and stenosis
severity was further assessed by polynomial regression analysis.
A p value 0.05 was considered signiﬁcant.
Results
Clinical data. There were no signiﬁcant differences with
regard to cardiovascular risk factors and extent of coronary
artery disease (Table 1). Patients without MI had a higher
ejection fraction (70  6 vs. 59  12, p  0.0001) and were
treated more frequently with calcium channel blockers (53%
vs. 8%, p  0.0001) than those with MI.
Hemodynamic data. Systolic blood pressure during PTCA
was higher in patients without than in those with MI (129 23
vs. 116  23 mm Hg, p  0.01), whereas heart rate was
signiﬁcantly higher in patients with MI (72  12 vs. 66  12,
p  0.05). Rate-pressure product did not differ signiﬁcantly
between study groups (MI: 8.6  2.3  103 mm Hg/beats per
min; no MI: 8.3  2.2  103 mm Hg/beats per min). Systolic
blood pressure, heart rate and rate-pressure product did not
change signiﬁcantly during adenosine-induced hyperemia
(baseline: 126 26 mm Hg, 70 14 beats/min, 8.8 2.4 103
mm Hg/beats per min; maximal hyperemia: 124  24 mm Hg,
68  14 beats/min, 8.4  2.3  103 mm Hg/beats per min).
There were no complications related to intracoronary ﬂow
velocity measurements in any patient studied, except for
transient total atrioventricular block during intracoronary
adenosine administration in four patients (infarct-related ar-
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tery in three), which lasted a maximum of 3 s, with no
hemodynamic compromise.
Angiographic data (Table 2). The distribution of target
arteries studied was similar, as was the reference diameter of
the target lesion and the diameter at the Doppler site, in each
group. Angiographic severity of the lesions before and after
PTCA (expressed as %DS), CSA and MLD did not differ
signiﬁcantly between study groups. In both groups, the mean
%DS of the lesions decreased signiﬁcantly as a result of
successful balloon angioplasty (65.8  9.5% and 65.2  10.1%
before PTCA; 38.2  11% and 34.6  11.5% after PTCA) in
the noninfarct-related and infarct-related vessels, respectively
(p  0.001).
Intracoronary Doppler ﬂow velocity data (Table 3). After
PTCA, APV values, coronary volumetric ﬂow (particularly
during hyperemia) and CFVR increased signiﬁcantly in both
study groups: CFVR increased from 1.50  0.45 to 2.21 0.74
in patients without MI and from 1.22  0.26 to 1.73  0.43 in
those with MI (p  0.0001 for both).
Comparison of coronary ﬂow velocity characteristics be-
tween study groups revealed no signiﬁcant differences in
infarct-related and noninfarct-related vessels for rest APV
values. However, hyperemic APV values were signiﬁcantly
lower in patients with than in those without MI, both before
PTCA (19.0  8.5 vs. 26.4  13.0 cm/s, p  0.05) and after
PTCA (37.2  11.7 vs. 45.4  16.0 cm/s, p  0.01).
Furthermore, a signiﬁcantly different CFVR value was
observed in patients with versus without MI both before
(1.22 0.26 vs. 1.50 0.45, p 0.05) and after PTCA (1.72
0.43 vs. 2.21  0.74, p  0.01) (Fig. 1). Further data analysis
after categorizing the study groups according to different
classes of stenosis severity (%DS 35, 35 to 50, 51 to 65 and
65) revealed that CFVR remained consistently lower in
patients with MI, independent of stenosis severity (Table 3).
The majority of patients (90%) had abnormal CFVR
values (2.0) before PTCA. After angiographically successful
Table 2. Angiographic and Hemodynamic Data for Target Lesions
No MI
(n  41)
MI
(n  36) p Value
Target vessel: RCA/LAD/LCx 10/24/7 12/16/8 0.5
Ref diam (mm)
Pre-PTCA 2.8  0.5 2.9  0.6 0.4
Post-PTCA 2.8  0.5 2.9  0.6
MLD (mm)
Pre-PTCA 0.9  0.3 1.0  0.3 0.1
Post-PTCA 1.7  0.4* 1.9  0.5*
%DS
Pre-PTCA 65.8  9.5 65.2  10.1 0.2
Post-PTCA 38.2  11.0* 34.6  11.5*
CSA (mm2)
Pre-PTCA 0.8  0.5 0.9  0.6 0.07
Post-PTCA 2.5  1.2* 3.1  1.7*
Diam at Doppler site (mm)
Pre-PTCA 2.3  0.4 2.3  0.6 0.05
Post-PTCA 2.3  0.4 2.4  0.7
SBP (mm Hg)
Pre-PTCA 127  20 113  24  0.05
Post-PTCA 132  26 118  23  0.05
DBP (mm Hg)
Pre-PTCA 67  10 64  13 0.1
Post-PTCA 70  12 65  13
MAP (mm Hg)
Pre-PTCA 90  16 85  16 NS
Post-PTCA 95  16† 87  15 NS
HR (beats/min)
Pre-PTCA 65  10 69  12 NS
Post-PTCA 66  13 74  13†  0.01
RPP  103
Pre-PTCA 8.5  2.0 7.9  2.0 0.5
Post-PTCA 8.7  2.5 8.8  2.3
*p  0.0001, †p  0.05, post-PTCA versus pre-PTCA. Data presented are
mean value  SD or number of lesions. CSA  cross-sectional area; DBP 
diastolic blood pressure; diam  diameter; %DS  percent diameter stenosis;
HR  heart rate; LAD  left anterior descending coronary artery; LCx  left
circumﬂex coronary artery; MAP  mean arterial pressure; MI  myocardial
infarction; MLD  minimal lumen diameter; PTCA  percutaneous translumi-
nal coronary angioplasty; RCA  right coronary artery; RPP  rate-pressure
product; SBP  systolic blood pressure.
Table 3. Intracoronary Flow Velocity Measurements in
Target Lesions
No MI
(n  41)
MI
(n  36) p Value
Basal APV (cm/s)
Pre-PTCA 17.3  6.6 15.5  6.5 0.6
Post-PTCA 22.0  8.9* 22.3  8.0*
Hyperemic APV (cm/s)
Pre-PTCA 26.4  13.0 19.0  8.5  0.05
Post-PTCA 45.4  16.0† 37.2  11.7†  0.01
Basal DSVR
Pre-PTCA 1.6  0.8 1.6  1.3 0.8
Post-PTCA 1.8  0.9 1.4  0.4
Hyperemic DSVR
Pre-PTCA 1.3  0.7 1.5  1.6 0.6
Post-PTCA 1.4  0.3 1.4  0.4
Basal ﬂow (ml/min)
Pre-PTCA 21.7  11.0 20.9  14.0 0.5
Post-PTCA 26.7  13.6‡ 31.4  18.4*
Hyperemic ﬂow (ml/min)
Pre-PTCA 34.0  22.8 25.7  17.6 0.3
Post-PTCA 56.2  29.1* 53.0  30.7†
CFVR
Pre-PTCA 1.50  0.45 1.22  0.22  0.05
Post-PTCA 2.21  0.74† 1.72  0.43*  0.01
%DS
35 2.21  0.66 1.84  0.52 NS
(n  17) (n  19)
35–50 2.24  0.81 1.60  0.27  0.01
(n  23) (n  18)
51–65 1.81 0.45 1.33  0.33  0.01
(n  20) (n  16)
65 1.23  0.19 1.11  0.08  0.05
(n  22) (n  19)
*p  0.001, †p  0.0001, ‡p  0.05, post-PTCA versus pre-PTCA. Data
presented are mean value  SD or number of lesions. APV  average peak
velocity; CFVR  coronary ﬂow velocity reserve; DSVR  diastolic/systolic
velocity ratio; other abbreviations as in Table 2.
1715JACC Vol. 28, No. 7 CLAEYS ET AL.
December 1996:1712–9 CORONARY FLOW RESERVE DURING PTCA AFTER MI
PTCA, CFVR values remained abnormal in 29 patients with
MI (80%) and in 18 without MI (44%) (p  0.001, MI vs. no
MI).
The phasic velocity pattern (Table 3, DSVR values) did not
differ between study groups. The right coronary artery tended
to have less diastolic predominance than the left anterior
descending coronary artery, particularly after PTCA, although
the difference did not reach signiﬁcance (post-PTCA DSVR:
1.3 0.3 vs. 1.8 0.4 for no MI; 1.3 0.3 vs. 1.9 0.9 for MI,
respectively).
Determinants of CFVR. In both study groups, CFVR was
related to a variety of factors, including clinical, hemodynamic
and angiographic factors and residual viability, expressed as
relative infarct size. From all studied factors, forward stepwise
linear regression analysis selected angiographic stenosis sever-
ity as the most important independent determinant of CFVR
both in patients with and without MI (Table 4). Besides
angiographic stenosis severity, heart rate was the only other
independent factor that signiﬁcantly affected CFVR in both
study groups.
Nonlinear regression analysis showed a signiﬁcant but
moderate correlation between CFVR and stenosis severity
(%DS) for all lesions measured (before and after PTCA: r 
0.59, p  0.0001 for MI; r  0.58, p  0.0001 for no MI) (Fig.
2). Further analysis revealed that the relation between CFVR
and %DS is mainly determined by pre-PTCA measurements
because no signiﬁcant correlation was found between CFVR
and stenosis severity after PTCA in both study groups (r 0.05
and r  0.15 for patients with and without MI, respectively).
In the present study, relative infarct size, which was used as
a scintigraphic marker of residual viability, averaged 49 34%
(range 0% to 100%). In the lesions studied after PTCA, CFVR
was not correlated with the amount of residual viability (r 
0.07, p  NS) (Fig. 3). Patients with an extensive infarct
(relative infarct size 50%) and those with a small infarct
relative infarct size 50%) had comparable levels of post-
PTCA CFVR (1.6  0.3 vs. 1.8  0.5, p  NS). In addition,
APV values and coronary ﬂow variables during baseline con-
ditions and during maximal hyperemia showed a poor nonsig-
niﬁcant correlation with residual viability. The time delay
between acute MI and coronary ﬂow measurements during
angioplasty did not signiﬁcantly affect CFVR (r  0.12 both
before and after PTCA).
Figure 1. Boxplot showing distribution (10th, 25th, 50th, 75th, 90th
percentiles) of CFVR obtained before and after PTCA in patients with
(hatched boxes) and without MI (open boxes). A signiﬁcantly lower
CFVR value was observed in patients with a recent MI both before and
after PTCA.
Table 4. Determinants of Coronary Flow Velocity Reserve: Stepwise
Regression Analysis
Variable
No MI
(F to enter)
MI
(F to enter)
%DS 34.3 35.2
HR (beats/min) 15.0 4.6
Relative infarct size (%) — 0.5
Time delay: MI to PTCA (days) — 0.7
SBP (mm Hg) 1.1 1.7
RPP (mm Hg  beats/min) 0.4 1.5
Ejection fraction (%) 0.7 0.3
Cholesterol (mg%) 3.8 0.7
Risk factors 0.005 2.0
Age 0.6 0.2
Intake of Ca channel blocker 1.3 0.2
Abbreviations as in Table 2; —  not applicable.
Figure 2. Scatterplots showing relation of CFVR to stenosis severity
(%DS) for all measured lesions before and after PTCA. A signiﬁcant
but moderate nonlinear correlation was found both in patients without
(top) and with MI (bottom): y a bx2, where a 2.5, and b 2.3
104 for patients without MI, and a  1.8 and b  1.4  104 for
patients with MI.
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Discussion
In the present study we investigated the post-stenotic ﬂow
velocity characteristics of the infarct-related vessel before and
after PTCA. We demonstrated that CFVR values were signif-
icantly lower in patients with a recent MI than in those without
MI and that CFVR remained severely impaired even after
angiographically successful PTCA. Despite the presence of this
postreperfusion impairment of the coronary vasodilating re-
sponse, CFVR was mainly related to stenosis severity, not to
the amount of residual viability.
Postreperfusion-related impairment of coronary vasodilat-
ing response. In the present study, CFVR values were much
lower in infarct-related than in noninfarct-related vessels over
a wide range of stenosis severity. Baseline characteristics did
not differ signiﬁcantly between study groups, except for heart
rate and systolic blood pressure. It has been shown (19) that
major hemodynamic changes may induce a substantial de-
crease in CFVR, mainly through an increase in baseline
coronary ﬂow blood ﬂow. Because differences in heart rate and
systolic blood pressure were small, and since baseline APV did
not differ between both groups, it is unlikely that the observed
differences in CFVR were due to differences in hemodynamic
status between both study groups.
The lower coronary ﬂow reserve values in patients with MI
were related to lower hyperemic APV values, suggesting
impaired vessel resistance in the reperfused myocardium.
Differences in calculated hyperemic blood ﬂow values between
the two study groups were less prominent, probably due to the
high variation induced by individual disparity of the vessel size
at the Doppler site.
Impairment of coronary ﬂow reserve in patients with a
recent MI has been recognized by previous investigators using
positron emission tomography or videodensitometry (12,20)
and may reﬂect the impaired myocardial vasodilating response
from postreperfusion-related microvascular injury (10,21).
Prolonged ischemia, resulting in cellular injury, may initiate
local inﬂammatory responses, including accumulation of neu-
trophils and production of leukotrienes, thereby increasing
vascular permeability (10,22,23). Increasing vascular perme-
ability completes a vicious circle by exacerbating interstitial
edema and extravascular resistance to blood ﬂow. Beyond the
microvascular injury, patients with a recent MI may also show
an abnormal vasomotor response with inappropriate constric-
tion of the small resistance vessels as a result of the release by
platelets of vasoactive substances (thromboxane A2, serotonin,
thrombin) (10,24). Thus, the reduced CFVR in patients with a
recent MI may reﬂect severe impairment of the functional
integrity of the microcirculation resulting from microvascular
damage or abnormal vasomotor response of the small resis-
tance vessels.
It has recently been shown (12,25,26) that the coronary
vasodilatory reserve after acute MI is most severely impaired
early after reperfusion and improves gradually over 6 months
without reaching normal values, suggesting that the impaired
CFVR is mediated by a process of microvascular stunning that
is partially reversible over time. In the present study, no
signiﬁcant correlation was found between CFVR and the time
delay between MI and ﬂow velocity measurements, suggesting
that no great spontaneous changes had occurred in the study
patients during the subacute phase (day 4 to 30) of an acute MI.
Determinants of CFVR. Coronary blood ﬂow and the
coronary ﬂow reserve depend on many factors, including
variable coronary stenosis geometry, hemodynamic factors, left
ventricular hypertrophy, MI, resistive vessel dysfunction result-
ing from atherosclerosis and extent of collateral circulation
(19,27–31). Among a variety of factors evaluated in the present
study, angiographic stenosis severity was the most important
determinant of CFVR both in patients with and without MI
with a correlation coefﬁcient of r  0.59 and r  0.58,
respectively. Lack of close correlation between angiographic
stenosis severity and CFVR is consistent with previous studies
performed in patients without a previous MI (13) and may
indicate that quantitative angiographic analysis of stenosis
severity does not always reﬂect the functional signiﬁcance of
the target stenosis. This ﬁnding was recently demonstrated by
Miller et al. (6) and Joye et al. (7), who reported intracoronary
Doppler ﬂow velocity measurements in noninfarct-related
arteries with intermediate stenosis severity and found that the
Doppler-derived post-stenotic ﬂow reserve correlated better
with stress perfusion scintigraphy than with angiographic ste-
nosis severity. Furthermore, CFVR measurement reﬂects both
epicardial and myocardial ﬂow capacity, and alterations in the
microcirculation will interfere with the relation between
CFVR and angiographic stenosis severity and may thus ac-
count for the data scatter.
In the present study the relation between CFVR and
angiographic stenosis severity was determined mainly by pre-
PTCA measurements, which is in agreement with other angio-
plasty studies performed in noninfarct-related arteries (32–34).
Furthermore, a substantial proportion of patients had abnor-
mal CFVR values (2.0) after successful angioplasty (44% for
no MI, 80% for MI). Reasons for the high rate of abnormal
post-PTCA CFVR levels, even in patients without MI, include
inadequate lumen expansion (35), abnormalities in autoregu-
lation resulting from long-standing ischemia with release of
local factors that affect coronary vasomotor tone (24,36) and
an increase in baseline ﬂow that would obscure signiﬁcant
Figure 3. Scatterplot showing the relation of CFVR after PTCA to
relative infarct size, as assessed scintigraphically. No signiﬁcant corre-
lation was found (r  0.07, p  NS).
1717JACC Vol. 28, No. 7 CLAEYS ET AL.
December 1996:1712–9 CORONARY FLOW RESERVE DURING PTCA AFTER MI
changes in the hyperemic/baseline ﬂow ratio (33,37). We
attempted to prevent changes in vasomotor tone by inducing
constant maximal epicardial coronary vasodilation by means of
intracoronary and intravenous administration of isosorbide
dinitrate. Furthermore, CFVR measurement after PTCA were
obtained 15 min after the last inﬂation, allowing the return of
baseline APV values to the steady state.
Stepwise linear regression analysis indicated heart rate as
second independent determinant of CFVR in both study
groups. The heart rate dependency of CFVR has been shown
in studies assessing the variability and reproducibility of ﬂow
velocity measurements (19,31,38).
In the present study, coronary ﬂow measurements, both
during baseline conditions and maximal hyperemia, were not
related to the amount of residual viability as assessed scinti-
graphically and could not discriminate patients with an exten-
sive infarction from those with a small infarction. These data
suggest that the coronary vasodilating capacity was not affected
by the amount of microvascular necrosis and support the idea
that impaired CFVR is instead related to the degree of injury
of the remaining microvascular circulation. Until now, only few
data are available that related intracoronary Doppler ﬂow
measurements with viability. A recent study by Kim et al. (39)
in small number of post-MI patients suggested that CFR
measurements during diagnostic catheterization might be use-
ful to predict functional recovery. However, functional recov-
ery does not always equate residual viability because the
process of functional recovery is also dependent on other
factors, including severity of the residual infarct-related steno-
sis (40). Furthermore, most of these patients had signiﬁcant
infarct-related stenosis, which might generate some uncer-
tainty, especially in small series, as to whether disparities in
coronary ﬂow reserve corresponded to the presence or absence
of functional recovery and not to differences in epicardial
vessel resistance. To avoid the confounding effect of residual
stenosis on the relation between coronary ﬂow reserve and
viability, only post-PTCA coronary ﬂow reserve values were
analyzed for that purpose in the present study.
The relation between ﬂow and viability has mainly been
investigated in studies using positron emission tomography
with nitrogen-13 ammonia as the ﬂow tracer and ﬂuorine-18
ﬂuoredoxyglucose as the viability tracer (41–44). In those
studies, regional blood ﬂow was lower in nonviable than viable
regions. However, these studies focused on regional ﬂow,
whereas in the present study, ﬂow variables were measured
within the infarct-related artery, which reﬂects a weighted
average of the ﬂow characteristics of different areas (viable and
nonviable) within the region supplied by the target vessel. An
additional explanation for the lack of correlation between ﬂow
and viability in the present study is the presence of high data
scatter due to variations in hemodynamic status and vessel size
in the study patients.
Limitations of the study. Several limitations of the present
study deserve further consideration. Coronary ﬂow velocity
measurements of the infarct region were compared with ﬂow
velocity measurements of normal myocardial regions by com-
paring data from patients with MI with those from patients
without MI. Flow velocity measurements during PTCA of a
noninfarct-related vessel stenosis in the same patients might
have allowed more accurate comparison but was not feasible
because most patients with MI had single-vessel disease or
noninfarct-related lesions not suitable for PTCA. Inaccuracies
in data interpretation, related to a nonpaired comparative
study design, could be restricted to a minimum because both
study groups were well matched with regard to clinical, hemo-
dynamic and angiographic variables.
The technical limitations of obtaining satisfactory ﬂow
velocity signals have been described in detail elsewhere
(7,33,45). We tried to avoid these limitations by careful patient
selection (e.g., patients with a narrow ostium, tortuous target
vessel or multiple serial distal lesions were excluded) and by
appropriate positioning of the Doppler guide wire away from
regions of nonlaminar ﬂow (e.g., no Doppler sampling at the
site of a great branch or directed to the vessel wall).
Estimation of residual viability was based on a semiquanti-
tative assessment of infarct size and infarct risk area. Although
quantitative analysis allows more accurate distinction between
viable and necrotic areas, it is unlikely that the use of more
sophisticated image analysis techniques would have altered the
ﬁnding that CFVR was unrelated to myocardial viability.
Finally, CFVR measurements were performed 4 to 30 days
after acute MI. In view of a possible time-dependent change in
CFVR after MI, our data cannot be extrapolated to CFVR
measurements carried out very early (48 h) or late (1
month) after the acute MI.
Clinical implications. Identiﬁcation of myocardial viability
and residual ischemia after MI is highly relevant to avoid
inappropriate mechanical interventions in patients who have
angiographically signiﬁcant coronary artery stenosis. The
present study demonstrated that intracoronary ﬂow velocity
measurements were not able to assess post-MI residual viabil-
ity. With regard to detection of ischemia within the infarct
region, our data emphasized that the commonly used coronary
ﬂow reserve criteria for ischemia, based on studies in patients
with stable angina, cannot be applied to patients with MI
because of the impaired vasodilating capacity of the reperfused
myocardium. Other, probably lower, reference values of coro-
nary ﬂow reserve remain to be determined in patients with a
recent MI before its use can be recommended for the func-
tional assessment of infarct-related vessel stenosis.
We are deeply grateful to Morton J. Kern, MD, FACC for comments and
constructive advice during manuscript preparation. We are also grateful to the
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support.
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